LUNG TRANSPLANT; COMPLICATIONS
Clinical trials for LUNG TRANSPLANT; COMPLICATIONS explained in plain language.
Never miss a new study
Get alerted when new LUNG TRANSPLANT; COMPLICATIONS trials appear
Sign up with your email to follow new studies for LUNG TRANSPLANT; COMPLICATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inhaled drug shows promise for lung transplant rejection in small trial
Disease control CompletedThis study tested an inhaled form of cyclosporine A (L-CsA) added to standard care in 62 single lung transplant patients with chronic lung rejection (bronchiolitis obliterans). The goal was to see if the combination could slow the decline in lung function over 48 weeks compared t…
Matched conditions: LUNG TRANSPLANT; COMPLICATIONS
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Jun 16, 2026 22:21 UTC
-
Lung transplant patients test app to skip long hospital days
Disease control CompletedThis study tested whether lung transplant patients can safely use a smartphone app and a home breathing test instead of some in-person hospital check-ups. 76 patients were split into two groups: one received standard care, the other used the app to report symptoms and lung functi…
Matched conditions: LUNG TRANSPLANT; COMPLICATIONS
Phase: NA • Sponsor: University of Manchester • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Inhaled drug shows promise for lung transplant patients with chronic rejection
Disease control CompletedThis study tested an inhaled form of cyclosporine A (L-CsA) added to standard care for people with chronic lung rejection after a double lung transplant. The goal was to see if it could improve lung function compared to standard care alone. 169 adults who had a double lung transp…
Matched conditions: LUNG TRANSPLANT; COMPLICATIONS
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC